ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/07 | 1,281 | 1,281 | 1,251 | 1,251 | -22 | -1.7% | 502,600 |
| 2024/10/04 | 1,265 | 1,284 | 1,264 | 1,273 | +6 | +0.5% | 348,100 |
| 2024/10/03 | 1,234 | 1,276 | 1,221 | 1,267 | +51 | +4.2% | 741,400 |
| 2024/10/02 | 1,230 | 1,247 | 1,211 | 1,216 | -10 | -0.8% | 670,500 |
| 2024/10/01 | 1,234 | 1,240 | 1,212 | 1,226 | -6 | -0.5% | 739,300 |
| 2024/09/30 | 1,255 | 1,281 | 1,224 | 1,232 | -65 | -5% | 1,199,700 |
| 2024/09/27 | 1,313 | 1,320 | 1,288 | 1,297 | -11 | -0.8% | 561,200 |
| 2024/09/26 | 1,289 | 1,308 | 1,285 | 1,308 | +27 | +2.1% | 698,000 |
| 2024/09/25 | 1,310 | 1,314 | 1,281 | 1,281 | -32 | -2.4% | 605,100 |
| 2024/09/24 | 1,331 | 1,337 | 1,304 | 1,313 | -18 | -1.4% | 574,100 |
| 2024/09/20 | 1,350 | 1,357 | 1,327 | 1,331 | +9 | +0.7% | 1,050,600 |
| 2024/09/19 | 1,308 | 1,326 | 1,304 | 1,322 | +23 | +1.8% | 505,800 |
| 2024/09/18 | 1,279 | 1,299 | 1,273 | 1,299 | +34 | +2.7% | 557,100 |
| 2024/09/17 | 1,305 | 1,317 | 1,237 | 1,265 | -33 | -2.5% | 1,009,600 |
| 2024/09/13 | 1,330 | 1,335 | 1,287 | 1,298 | -43 | -3.2% | 766,900 |
| 2024/09/12 | 1,321 | 1,342 | 1,305 | 1,341 | +50 | +3.9% | 671,900 |
| 2024/09/11 | 1,295 | 1,310 | 1,276 | 1,291 | +8 | +0.6% | 887,700 |
| 2024/09/10 | 1,285 | 1,294 | 1,270 | 1,283 | +1 | +0.1% | 569,600 |
| 2024/09/09 | 1,272 | 1,301 | 1,265 | 1,282 | -20 | -1.5% | 1,334,000 |
| 2024/09/06 | 1,347 | 1,351 | 1,281 | 1,302 | -37 | -2.8% | 1,555,800 |
| 2024/09/05 | 1,320 | 1,353 | 1,316 | 1,339 | +9 | +0.7% | 1,167,900 |
| 2024/09/04 | 1,369 | 1,378 | 1,328 | 1,330 | -76 | -5.4% | 1,922,800 |
| 2024/09/03 | 1,415 | 1,445 | 1,386 | 1,406 | -4 | -0.3% | 1,647,600 |
| 2024/09/02 | 1,458 | 1,472 | 1,407 | 1,410 | +10 | +0.7% | 2,791,800 |
| 2024/08/30 | 1,471 | 1,500 | 1,376 | 1,400 | -59 | -4% | 4,751,100 |
| 2024/08/29 | 1,480 | 1,482 | 1,394 | 1,459 | -258 | -15% | 6,130,500 |
| 2024/08/28 | 1,688 | 1,717 | 1,672 | 1,717 | +33 | +2% | 352,900 |
| 2024/08/27 | 1,720 | 1,747 | 1,676 | 1,684 | -30 | -1.8% | 808,000 |
| 2024/08/26 | 1,730 | 1,730 | 1,707 | 1,714 | -17 | -1% | 410,300 |
| 2024/08/23 | 1,725 | 1,732 | 1,699 | 1,731 | +5 | +0.3% | 608,000 |
| 2024/08/22 | 1,670 | 1,733 | 1,665 | 1,726 | +66 | +4% | 755,900 |
| 2024/08/21 | 1,693 | 1,695 | 1,644 | 1,660 | -42 | -2.5% | 582,900 |
| 2024/08/20 | 1,671 | 1,703 | 1,652 | 1,702 | +37 | +2.2% | 949,400 |
| 2024/08/19 | 1,644 | 1,677 | 1,629 | 1,665 | +17 | +1% | 633,000 |
| 2024/08/16 | 1,580 | 1,654 | 1,577 | 1,648 | +92 | +5.9% | 1,104,500 |
| 2024/08/15 | 1,565 | 1,571 | 1,545 | 1,556 | +6 | +0.4% | 506,400 |
| 2024/08/14 | 1,585 | 1,586 | 1,534 | 1,550 | -12 | -0.8% | 862,300 |
| 2024/08/13 | 1,502 | 1,582 | 1,495 | 1,562 | +71 | +4.8% | 984,900 |
| 2024/08/09 | 1,518 | 1,523 | 1,473 | 1,491 | +3 | +0.2% | 704,100 |
| 2024/08/08 | 1,474 | 1,507 | 1,466 | 1,488 | +10 | +0.7% | 586,800 |
| 2024/08/07 | 1,425 | 1,507 | 1,404 | 1,478 | +24 | +1.7% | 1,071,600 |
| 2024/08/06 | 1,421 | 1,474 | 1,413 | 1,454 | +75 | +5.4% | 2,163,600 |
| 2024/08/05 | 1,479 | 1,528 | 1,343 | 1,379 | -180 | -11.5% | 2,189,700 |
| 2024/08/02 | 1,643 | 1,660 | 1,550 | 1,559 | -104 | -6.3% | 1,534,000 |
| 2024/08/01 | 1,682 | 1,690 | 1,647 | 1,663 | -17 | -1% | 605,900 |
| 2024/07/31 | 1,696 | 1,701 | 1,642 | 1,680 | -22 | -1.3% | 617,000 |
| 2024/07/30 | 1,691 | 1,709 | 1,678 | 1,702 | +9 | +0.5% | 913,700 |
| 2024/07/29 | 1,695 | 1,702 | 1,683 | 1,693 | +3 | +0.2% | 499,100 |
| 2024/07/26 | 1,687 | 1,703 | 1,668 | 1,690 | +3 | +0.2% | 629,200 |
| 2024/07/25 | 1,703 | 1,726 | 1,683 | 1,687 | -17 | -1% | 1,519,600 |
201～
250
件表示中 / 5144件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 92,300円 | +20.3% | - | 0.00% | 163.65倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 154,300円 | -2.4% | -52.3% | 3.69% | 18.47倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 223,600円 | +4.1% | -3.1% | 2.59% | 19.42倍 | 1.69倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ＪＣＲファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
